Improving tracking of AMR bacteria in hospitals using new genomic technique
The spread of multiple bacteria could be tracked simultaneously through sequencing method
Read More
Tag: Wellcome Sanger Institute
Study reveals new insights into ‘gene misbehaviour’ in healthy populations
The findings could support investigations into human genetics and various complex diseases
Read More
Study reveals mobile phone data can help map the spread of pathogens
Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide
Read More
Researchers find whole genome sequencing improves care for paediatric cancer
Affecting around 3,755 young people in the UK every year, leukaemia is the most commonly diagnosed cancer in children
Read More
New collaboration aims to research early mutations in rare blood disorder
Langerhans cell histiocytosis currently affects around one in 200,000 children in the UK
Read More
Researchers reveal genetic makeup could identify treatment options for sepsis
The serious condition is responsible for approximately 11 million deaths worldwide every year
Read More
Researchers identify genetic changes responsible for rare childhood immune disorders
Affecting the immune system, various forms of SCID are estimated to affect one in 75,000 to 100,000 newborns
Read More
Study reveals how specific nasal cells protect against COVID-19 in paediatric patients
The findings suggest why children tend to experience milder symptoms compared to older adults
Read More
Study reveals antibiotic use is not the only driver of antibiotic resistance
Researchers compared 20 years of antibiotic use on E. coli in the UK and Norway
Read More
Researchers identify new genetic target for acute myeloid leukaemia
Targeting a specific mutation in the CUX1 gene may offer a ‘new therapy avenue’ for AML patients
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
